Protenus is a technology company.
Protenus has raised $56.0M across 5 funding rounds.
Key people at Protenus.
Protenus has raised $56.0M in total across 5 funding rounds.
Protenus has raised $56.0M in total across 5 funding rounds.
Protenus's investors include Arthur Ventures, F-Prime Capital Partners, Town Hall Ventures, Kaiser Permanente Ventures.
Protenus is a healthcare compliance analytics platform that uses AI to monitor electronic health records (EHR), detect patient privacy violations, and prevent drug diversion in hospitals and health systems.[1][2][3][4] It serves over 200 healthcare organizations by providing cloud-based tools for real-time analytics, false positive filtration, and behavioral pattern detection to protect patient data and ensure regulatory compliance.[1][3][4] The company raised $57.15M before being acquired by Bluesight in January 2025, marking strong growth from its startup roots to a market leader in healthcare cybersecurity.[1][2][4]
Protenus was founded in 2014 in Baltimore, Maryland, by medical students Nick Culbertson and Robert Lord through the DreamIt Health Baltimore accelerator program at Johns Hopkins University.[1][4] Initially exploring general digital health innovations, the duo pivoted after connecting with Peter Greene, Chief Medical Information Officer at Johns Hopkins Medicine, who highlighted real-world pain points in EHR privacy monitoring.[4] This led to Protenus' core product, with Johns Hopkins becoming its first customer and providing essential validation that facilitated early traction through industry references.[4] The company's evolution from a student project to serving 200+ organizations culminated in its 2025 acquisition by Bluesight.[1][2][4]
Protenus stands out in healthcare compliance through these key strengths:
Protenus rides the wave of AI-driven healthcare cybersecurity, addressing surging EHR adoption amid rising data breaches and regulatory pressures like HIPAA.[1][2][3] Its timing aligns with post-pandemic digital health acceleration, where health systems manage vast patient data but struggle with insider threats and diversion—issues amplified by workforce shortages and complex EHR systems.[3][4] Market forces like increasing cyber risks and compliance mandates favor Protenus, positioning it (now under Bluesight) to influence ecosystem standards by combining compliance analytics with inventory/procurement tools.[1][4] This enhances broader trust in digital health, enabling safer AI integration in care delivery.
Post-acquisition by Bluesight in January 2025, Protenus will likely expand into integrated compliance-inventory suites, amplifying its reach across hospital pharmacies and systems.[1][2][4] Trends like generative AI in healthcare and stricter global privacy laws (e.g., evolutions of GDPR/HIPAA) will propel demand, potentially driving product innovations in predictive diversion prevention and multi-EHR interoperability.[1][3] Its influence may evolve from standalone analytics leader to a cornerstone of enterprise health tech stacks, sustaining momentum through Bluesight's resources while upholding its Johns Hopkins-honed mission of patient safety.
Key people at Protenus.
Protenus has raised $56.0M across 5 funding rounds. Most recently, it raised $21.0M Series D in June 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2021 | $21.0M Series D | Arthur Ventures, F-Prime Capital Partners, Town Hall Ventures | |
| Aug 1, 2019 | $17.0M Series C | Arthur Ventures, F-Prime Capital Partners, Town Hall Ventures | |
| Jan 1, 2018 | $11.0M Series B | Arthur Ventures, F-Prime Capital Partners, Town Hall Ventures | |
| Jul 1, 2017 | $3.0M Series A | F-Prime Capital Partners, Kaiser Permanente Ventures, Town Hall Ventures | |
| Jan 1, 2016 | $4.0M Series A | Arthur Ventures |
